[EN] 4-ALKOXY-N- (2-HYDROXYCARBAMOYL-2-PIPERIDINYL-ETHYL) -BENZAMIDE COMPOUNDS AS SELECTIVE TACE-INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES [FR] COMPOSÉS DE 4-ALCOXY-N-(2-HYDROXYCARBAMOYL-2-PIPÉRIDINYLÉTHYL)BENZAMIDE EN TANT QU'INHIBITEURS DE TACE SÉLECTIFS DESTINÉS AU TRAITEMENT DE MALADIES INFLAMMATOIRES
4-ALKOXY-N- (2-HYDROXYCARBAMOYL-2-PIPERIDINYL-ETHYL) -BENZAMIDE COMPOUNDS AS SELECTIVE TACE-INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES
申请人:Clary Laurence
公开号:US20120226033A1
公开(公告)日:2012-09-06
The present invention relates to novel benzene-carboxamide compounds having a structure that corresponds to the general formula (I) below: and also to their method of synthesis and to their use in pharmaceutical compositions intended for use in human or veterinary medicine or else to their use in cosmetic compositions.
Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
申请人:Clary Laurence
公开号:US08772478B2
公开(公告)日:2014-07-08
Benzenesulfonamide compounds having a structure of the following general formula (I) are described. Also described, are methods for synthesizing the compounds, and to the use thereof in pharmaceutical compositions for human or veterinary medicine and in cosmetic compositions.
4-alkoxy-N-(2-hydroxycarbamoyl-2-piperidinyl-ethyl)-benzamide compounds as selective TACE-inhibitors for the treatment of inflammatory diseases
申请人:Clary Laurence
公开号:US09266848B2
公开(公告)日:2016-02-23
The present invention relates to novel benzene-carboxamide compounds having a structure that corresponds to the general formula (I) below: and also to their method of synthesis and to their use in pharmaceutical compositions intended for use in human or veterinary medicine or else to their use in cosmetic compositions.
NOVEL BENZENESULFONAMIDE COMPOUNDS, METHOD FOR SYNTHESIZING SAME, AND USE THEREOF IN MEDICINE AS WELL AS IN COSMETICS
申请人:Clary Laurence
公开号:US20120116072A1
公开(公告)日:2012-05-10
Benzenesulfonamide compounds having a structure of the following general formula (I) are described. Also described, are methods for synthesizing the compounds, and to the use thereof in pharmaceutical compositions for human or veterinary medicine and in cosmetic compositions.